Chair: Steven Kahn (USA)
| 17:45 – 17:50 | Welcome and introduction | Steven Kahn (USA) |
| 17:50 – 18:05 | Stepping up holistic care: incretin-based and novel combination therapies in obesity | John Wilding (GBR) |
| 18:05 – 18:20 | Taking the next step: the role of GLP-1RAs in the CKD and T2D nexus | Paola Fioretto (ITA) |
| 18:20 – 18:35 | At the end of the road: managing subclinical and clinical CVD with incretin-based and novel combination therapies | Subodh Verma (CAN) |
| 18:35 – 18:50 | Integrating MASH in the CKM syndrome: the potential role of GLP-1RAs for the missing link | Eric Lawitz (USA) |
| 18:50 – 18:55 | Looking into the future: advancing CKM management strategies | Steven Kahn (USA) |
| 18:55 – 19:15 | Q&A | All faculty |
- Wednesday, 17 September 2025
- 17:45 - 19:15 CEST
- Lima Hall
